KalVista Pharmaceuticals, Inc.: KalVista Pharmaceuticals Presents Patient-Focused Data at American College of Allergy, Asthma & Immunology (ACAAI) 2022 Meeting : vimarsana.com

Results show the impact of attacks on mental health, daily activities, and quality of life in people living with HAE - Real-world data demonstrate treatment burden associated with on-demand parenteral

Related Keywords

Louisville , Kentucky , United States , Utah , Los Angeles , Jarrod Aldom , Raffi Tachdjian , Douglash Jones , Andrew Crockett , Exchange Commission , Kalvista Pharmaceuticals Inc , School Of Medicine , American College Of Allergy , Corporate Communications , Nasdaq , Vista Pharmaceuticals , American College , Asthma Immunology , Event Reporting System , Chief Executive Officer , Hereditary Angioedema , Daily Living , Rocky Mountain Allergy , Tanner Clinic , World Treatment Burden Associated , Parenteral On Demand Therapies , Kalvista Pharmaceuticals , Securities Litigation Reform Act , Kalvista , Harmaceuticals , Resents , Atient , Ocused , Ata , American , Ollege , Llergy , Sthma , Mmunology , Acaai , 022 , Eeting ,